SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-043518
Filing Date
2023-02-21
Accepted
2023-02-21 16:20:42
Documents
13
Period of Report
2023-02-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d427260d8k.htm   iXBRL 8-K 49187
  Complete submission text file 0001193125-23-043518.txt   217099

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cmra-20230214.xsd EX-101.SCH 3931
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmra-20230214_def.xml EX-101.DEF 14503
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmra-20230214_lab.xml EX-101.LAB 24070
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmra-20230214_pre.xml EX-101.PRE 15601
7 EXTRACTED XBRL INSTANCE DOCUMENT d427260d8k_htm.xml XML 5395
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41403 | Film No.: 23648488
SIC: 2834 Pharmaceutical Preparations